https://www.selleckchem.com/pr....oducts/Elesclomol.ht
Conclusion PCI in CAV may be associated with increased in-hospital complications and higher resource utilization.Liposomes are among the most extensively applied drug carriers due to their excellent biocompatibility, controllable size and ease of modification. In the present study, we prepared untargeted liposomes (LP) and targeting liposomes modified with Arg-Gly-Asp (RGD-LP), and Doxorubicin Hydrochloride (DOX) or fluorescent probe was loaded. RGD-LP/DOX was identified to be uniformly spherical in size 131.2 ± 2.7 nm. Based on flow
Like
Comment
Share
